Market Overview:
The global operating room infection control products market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of hospital-acquired infections (HAIs) and rising demand for advanced infection control products. Based on type, the global operating room infection control products market is segmented into tablets and oral suspension. The oral suspension segment is expected to grow at a higher CAGR than the tablet segment during the forecast period. This can be attributed to the growing demand for advanced oral suspensions that help in controlling hospital-acquired infections effectively. Based on application, the global operating room infection control products market is divided into hospitals, retail pharmacies, and other applications such as clinics and diagnostic centers. Hospitals are estimated to account for a major share of this market in 2018 owing to increasing number of surgeries performed in these settings every year coupled with rising incidence of HAIs globally.
Product Definition:
Operating Room Infection Control Products are products that are used to help prevent the spread of infection in the operating room. They can include things like gowns, masks, gloves, and sterilization supplies. The importance of Operating Room Infection Control Products is that they can help keep patients safe from infection during surgery.
Tablets:
Tablets are small pieces of paper or thin layers of plastic that are coated with a drug and used to make a specific kind of dosage form for drugs. They come in different forms such as film, strip, and liquid-filled. The most common type is the tablet which is made up of excipients (a non-active substance) like dyes & fillers along with the active ingredient which can be an antibiotic or any other medicine.
Oral Suspension:
Oral suspension is a drug delivery method which involves the use of solid or liquid medication to be taken in the mouth. It allows for controlled release of drugs allowing for efficient absorption by the body tissues. The most common types of oral suspensions available today are toothpaste, mouthwash and gels/jellies containing codeine phosphate, chloramphenicol and doxylamine; all three products have different efficacies but serve similar purposes.
Application Insights:
The hospital application segment led the global operating room infection control products market in 2017. This is attributed to a rise in healthcare spending and increasing awareness about safe procedures among patients, visitors and staff. Furthermore, an increase in the number of hospitals across various regions has resulted in increased demand for these devices.
In addition, rising cases of Methicillin-resistant Staphylococcus aureus (MRSA) infections have created demand for surgical masks that can block out airborne pathogens such as MRSA and other common skin infections like chickenpox virus or staphylococcal scabs. These factors are expected to drive product demand over the forecast period from 2018 to 2030.
The retail pharmacy application segment is anticipated to witness significant growth over the forecast period owing to high product penetration along with growing emphasis on patient safety by pharmacists at retail pharmacies across various regions including North America, Europe and Asia Pacific.
Regional Analysis:
North America dominated the global market in 2017. The presence of sophisticated healthcare infrastructure, high adoption rate of advanced technologies, and increasing demand for efficient healthcare services are some factors driving the growth. Moreover, rising number of surgical procedures is also expected to drive regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing medical tourism and favorable government initiatives regarding construction of modern hospitals & clinics with up-to-date ORI standards. In addition, growing target population base due to rapid urbanization will support regional market expansion over next eight years.
Growth Factors:
- Increasing incidence of hospital-acquired infections (HAIs) and surgical site infections (SSIs) is driving the demand for OR infection control products.
- Growing awareness about the prevention of HAIs is propelling the adoption of OR infection control products.
- The increasing number of surgeries and growing demand for minimally invasive surgeries are fueling the growth of the market.
- Rising geriatric population is leading to an increase in cases of hospital-acquired infections, which in turn is boosting demand for OR infection control products.
- Technological advancements in OR infection control products are providing new opportunities for market growth
Scope Of The Report
Report Attributes
Report Details
Report Title
Operating Room Infection Control Products Market Research Report
By Type
Tablets, Oral Suspension
By Application
Hospital, Retail Pharmacy, Other
By Companies
Romark Laboratories, Chugai Pharmaceutical, Lupin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Operating Room Infection Control Products Market Report Segments:
The global Operating Room Infection Control Products market is segmented on the basis of:
Types
Tablets, Oral Suspension
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Retail Pharmacy, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Romark Laboratories
- Chugai Pharmaceutical
- Lupin
Highlights of The Operating Room Infection Control Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Oral Suspension
- By Application:
- Hospital
- Retail Pharmacy
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Operating Room Infection Control Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Operating room infection control products are designed to help prevent the spread of infection in an operating room. These products can include masks, gowns, gloves, and other equipment.
Some of the major companies in the operating room infection control products market are Romark Laboratories, Chugai Pharmaceutical, Lupin.
The operating room infection control products market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Operating Room Infection Control Products Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Operating Room Infection Control Products Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Operating Room Infection Control Products Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Operating Room Infection Control Products Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Operating Room Infection Control Products Market Size & Forecast, 2020-2028
4.5.1 Operating Room Infection Control Products Market Size and Y-o-Y Growth
4.5.2 Operating Room Infection Control Products Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tablets
5.2.2 Oral Suspension
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Operating Room Infection Control Products Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Operating Room Infection Control Products Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tablets
9.6.2 Oral Suspension
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Retail Pharmacy
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tablets
10.6.2 Oral Suspension
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Retail Pharmacy
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tablets
11.6.2 Oral Suspension
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Retail Pharmacy
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tablets
12.6.2 Oral Suspension
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Retail Pharmacy
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tablets
13.6.2 Oral Suspension
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Retail Pharmacy
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Operating Room Infection Control Products Market: Competitive Dashboard
14.2 Global Operating Room Infection Control Products Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Romark Laboratories
14.3.2 Chugai Pharmaceutical
14.3.3 Lupin
